Derivation and validation of REASON: A risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 474-479

  Ramos, Rafel ^a,e   Baena Díez, Jose Miguel ^b,h   Quesada, Miquel ^a,c,e   Solanas, Pascual ^a,e   Subirana, Isaac ^b   Sala, Joan ^d,e   Alzamora, Maite ^f   Forès, Rosa ^a,f   Masiá, Rafel ^d   Elosua, Roberto ^b   Grau, María ^b   Cordón, Ferran ^a,e   Pera, Guillem ^g   Rigo, Fernando ⁱ   Martí, Ruth ^a   Ponjoan, Anna ^a   Cerezo, Carlos ^a   Brugada, Ramon ^e   Marrugat, Jaume ^b  

^a Catalan Health Institute   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Hospital Josep Trueta   (Spain)

^e UNIVERSITY OF GIRONA   (Spain)

^f Sta Coloma de Gramenet   (Spain)

^g ICS   (Spain)

^h Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

ⁱ Balearic Islands Health Service   (Spain)

Author keywords

Ankle brachial index; Arteriosclerosis; Peripheral vascular disease; Primary prevention; Screening

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CALIBRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INTER SOCIETY CONSENSUS SCREENING CRITERIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PULSE PRESSURE; REGICOR AND ARTPER SCORE FOR ANKLE BRACHIAL INDEX SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY;

AGED; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SPAIN;

EID: 79151473282     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.015     Document Type: Article

References (26)

1. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Atherosclerosis 2007, 194:1-45.
2. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008, 117:743-753.
3. Comín E., Solanas P., Cabezas C., et al. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol 2007, 60:693-702.
4. Davidsson L., Fagerberg B., Bergström G., Schmidt C. Ultrasound-assessed plaque occurrence in the carotid and femoral arteries are independent predictors of cardiovascular events in middle-aged men during 10 years of follow-up. Atherosclerosis 2010, 209:469-473.
5. Grewal J., Anand S., Islam S., et al. Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population. Atherosclerosis 2008, 197:435-442.
6. Santos R.D., Nasir K. Insights into atherosclerosis from invasive and non-invasive imaging studies: should we treat subclinical atherosclerosis. Atherosclerosis 2009, 205:349-356.
7. Kollerits B., Heinrich J., Pichler M., et al. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-up. Atherosclerosis 2008, 198:214-222.
8. Heald C.L., Fowkes F.G.R., Murray G.D., Price J.F. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006, 189:61-69. Ankle Brachial Index Collaboration.
9. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality. A meta-analysis. JAMA 2008, 300:197-208. Ankle Brachial Index Collaboration.
10. Ramos R., Quesada M., Solanas P., et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009, 38:305-311.
11. Greenland P., Abrams J., Aurigemma G.P., et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation 2000, 101:e16-e22.
12. Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 2008, 118:961-967.
13. United States Preventive Services Task and Force Recommendation statement: screening for peripheral arterial disease 2005, Agency for Healthcare Research and Quality, Washington, DC, pp. 1-8.
14. U.S. Preventive Services Task Force Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:474-482.
15. Calonge N., Petitti D. Letter regarding article "The United States Preventive Services Task Force Recommendation Statement on Screening for Peripheral Arterial Disease: More Harm Than Benefit?" Circulation 2007, 115:e212.
16. Beckman J.A., Creager M.A., Jaff M.R. Response to letter regarding article "The United States Preventive Services Task Force Recommendation Statement on Screening for Peripheral Arterial Disease: More Harm Than Benefit?" Circulation 2007, 115:e213.
17. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33:S1-S75.
18. Alzamora M.T., Baena-Díez J.M., Sorribes M., et al. Peripheral arterial disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality. BMC Public Health 2007, 7:348.
19. Marrugat J., Subirana I., Comín E., et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health 2007, 61:40-47.
20. Leng G.C., Fowkes F.G. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992, 45:1101-1109.
21. Bendermacher B.L., Teijink J.A., Willigendael E.M., et al. Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule. Br J Gen Pract 2006, 56:932-937.
22. Makdisse M., Ramos L.R., Moreira F., et al. A risk score for predicting peripheral arterial disease in individuals 75 years or older. Arq Bras Cardiol 2007, 88:630-636.
23. Bendermacher B.L., Teijink J.A., Willigendael E.M., et al. A clinical prediction model for the presence of peripheral arterial disease - the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study. Vasc Med 2007, 12:5-11.
24. Perlstein T.S., Creager M.A. The ankle-brachial index as a biomarker of cardiovascular risk it's not just about the legs. Circulation 2009, 120:2033-2035.
25. Diehm C., Allenberg J.R., Pittrow D., et al. For the German epidemiological trial on ankle brachial index study group mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009, 120:2053-2061.
26. Hyatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.